Literature DB >> 18432259

Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma.

Maoxin Wu1, Lurmag Orta, Joan Gil, Gan Li, Alice Hu, David E Burstein.   

Abstract

The critical distinction of bronchioloalveolar carcinoma (BAC), well-differentiated adenocarcinoma (WDAC) of lung, adenomatous hyperplasia (AH) and atypical adenomatous hyperplasia (AAH), is based on morphological criteria alone, and is therefore potentially subjective. We examined expression of two markers, X-linked inhibitor of apoptosis protein (XIAP), the most potent of the inhibitor of apoptosis protein (IAP) family, and p63, a marker of bronchial reserve cells (BRC) and squamous cells, in these entities. H&E slides of 37 tissue blocks from 27 patients were reviewed and classified as AH (n=7), AAH (n=8), BAC (n=9) and WDAC (n=13). Immunostaining was performed on 4 mum sections with monoclonal anti-XIAP and monoclonal anti-p63. Granular or heterogeneous cytoplasmic staining for XIAP and nuclear staining for p63 were considered positive. Neither XIAP nor p63 were detected in normal lung alveolar cells. All seven AHs were negative for XIAP and negative or focally positive for p63. All eight AAHs were positive for XIAP and displayed p63 positivity in scattered cells. All BACs displayed XIAP positivity, which ranged from focal/weak to diffuse/strong. p63 was negative in seven and focally positive in two of nine BACs. Twelve of 13 WDACs showed XIAP positivity in a similar pattern to BAC; all were negative for p63. One aberrant case diagnosed on H & E as WDAC was negative for XIAP but strongly positive for p63. Significant XIAP expression appears to be useful for distinguishing AAH from AH. Commonality of XIAP staining in AAH, BAC and WDAC supports the possibility that AAH may be a pre-malignant lesion. The rarity of p63 expression confirms previous reports and supports a nonbronchial histogenesis of these entities. In contrast, diffuse p63 staining may facilitate the identification of rare cases that may have been misclassified as alveolar in origin based on morphology but may be of BRC origin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18432259     DOI: 10.1038/modpathol.2008.5

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

Review 1.  Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement.

Authors:  Hyojin Kim; Jin-Haeng Chung
Journal:  Transl Lung Cancer Res       Date:  2015-04

2.  Epidermal growth factor receptor gene amplification in atypical adenomatous hyperplasia of the lung.

Authors:  Maria G McIntire; Sandro Santagata; Keith Ligon; Lucian R Chirieac
Journal:  Am J Transl Res       Date:  2010-05-16       Impact factor: 4.060

3.  Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion.

Authors:  Jian Li; Zhen-Nan Li; Qian-Lei Bao; Li-Ping Ge; Xiao-Qin Li; Ping Chen
Journal:  Tumour Biol       Date:  2012-06-14

4.  [Active surveillance of localized prostate cancer. Significance of prostate core needle biopsies].

Authors:  J Rüschoff; P Middel; P Albers
Journal:  Pathologe       Date:  2008-09       Impact factor: 1.011

5.  Metagenes associated with survival in non-small cell lung cancer.

Authors:  Egon Urgard; Tõnu Vooder; Urmo Võsa; Kristjan Välk; Mingming Liu; Cheng Luo; Fabian Hoti; Retlav Roosipuu; Tarmo Annilo; Jukka Laine; Christopher M Frenz; Liqing Zhang; Andres Metspalu
Journal:  Cancer Inform       Date:  2011-06-02

6.  TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit.

Authors:  Daniela Cabibi; Sandro Bellavia; Antonino Giulio Giannone; Nadia Barraco; Calogero Cipolla; Anna Martorana; Vito Rodolico; Massimo Cajozzo; Ada Maria Florena
Journal:  Diagnostics (Basel)       Date:  2020-01-06

7.  Distal-type bronchiolar adenoma of the lung expressing p16INK4a - morphologic, immunohistochemical, ultrastructural and genomic analysis - report of a case and review of the literature.

Authors:  Mitsuhiro Tachibana; Masao Saito; Jun Kobayashi; Tadahiro Isono; Yasushi Yatabe; Yutaka Tsutsumi
Journal:  Pathol Int       Date:  2020-02-06       Impact factor: 2.534

Review 8.  Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review.

Authors:  Aldo Pezzuto; Michela D'Ascanio; Alberto Ricci; Alessandra Pagliuca; Elisabetta Carico
Journal:  Thorac Cancer       Date:  2020-09-18       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.